Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Apr;72(1):168–173.

Uptake of antibody directed cytotoxic liposomes by CD3 on human T cells.

A G Gray 1, J Morgan 1, D C Linch 1, E R Huehns 1
PMCID: PMC1541503  PMID: 3260836

Abstract

Using polyclonal human T cells and anti-CD3 monoclonal antibodies we have shown that small unilamellar liposomes covalently coupled with protein A become bound to T cells and not to B cells and that the binding was a specific liposome-antibody-receptor interaction. Intracellular delivery of liposome contents was demonstrated by the use of encapsulated carboxyfluorescein and flow cytometry and the transfer of membrane-bound liposomal carboxyfluorescein was virtually complete in 30 min. Liposomes containing methotrexate inhibited the growth of PHA-stimulated peripheral blood lymphocytes by 90%, after 48 h incubation. Potential applications are proposed in the study of the behaviour of surface membrane components and in T cell depletion and purging of bone marrow.

Full text

PDF
171

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beverley P. C., Callard R. E. Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody. Eur J Immunol. 1981 Apr;11(4):329–334. doi: 10.1002/eji.1830110412. [DOI] [PubMed] [Google Scholar]
  2. Branch D. R., Petz L. D. A new reagent (ZZAP) having multiple applications in immunohematology. Am J Clin Pathol. 1982 Aug;78(2):161–167. doi: 10.1093/ajcp/78.2.161. [DOI] [PubMed] [Google Scholar]
  3. Huang A., Kennel S. J., Huang L. Interactions of immunoliposomes with target cells. J Biol Chem. 1983 Nov 25;258(22):14034–14040. [PubMed] [Google Scholar]
  4. Kan E. A., Wang C. Y., Wang L. C., Evans R. L. Noncovalently bonded subunits of 22 and 28 kd are rapidly internalized by T cells reacted with anti-Leu-4 antibody. J Immunol. 1983 Aug;131(2):536–539. [PubMed] [Google Scholar]
  5. Leserman L. D., Barbet J., Kourilsky F., Weinstein J. N. Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature. 1980 Dec 11;288(5791):602–604. doi: 10.1038/288602a0. [DOI] [PubMed] [Google Scholar]
  6. Machy P., Barbet J., Leserman L. D. Differential endocytosis of T and B lymphocyte surface molecules evaluated with antibody-bearing fluorescent liposomes containing methotrexate. Proc Natl Acad Sci U S A. 1982 Jul;79(13):4148–4152. doi: 10.1073/pnas.79.13.4148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Prentice H. G., Blacklock H. A., Janossy G., Gilmore M. J., Price-Jones L., Tidman N., Trejdosiewicz L. K., Skeggs D. B., Panjwani D., Ball S. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet. 1984 Mar 3;1(8375):472–476. doi: 10.1016/s0140-6736(84)92848-4. [DOI] [PubMed] [Google Scholar]
  8. Weinstein J. N. Liposomes as drug carriers in cancer therapy. Cancer Treat Rep. 1984 Jan;68(1):127–135. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES